DCF — WASHINGTON REGIONAL MEDICAL CENTER
Enterprise Value: $-174.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-174.8M
Enterprise Value
$-63.8M
PV of Cash Flows
$-111.0M
PV of Terminal Value
$-178.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $363.4M | $-6.2M | -2.0% | $-21.6M | $-19.6M |
| Year 2 | $374.3M | $-2.7M | -1.0% | $-18.5M | $-15.3M |
| Year 3 | $385.5M | $1.1M | 0.0% | $-15.2M | $-11.4M |
| Year 4 | $397.1M | $3.1M | 1.0% | $-13.7M | $-9.3M |
| Year 5 | $409.0M | $4.2M | 1.0% | $-13.1M | $-8.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-174.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$352.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.022140969015775162
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5